Recent studies have shown that overexpressed MGP could be found in various types of cancer, including breast cancer, glioblastoma, primary renal cancer, testicular cancer, prostatic carcinomas, and ovarian cancer, and they suggested that it may be associated with tumor progression and invasion.29 Here, MGP is linked to breast carcinoma.